Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary
- Tilmann Bochtler
- , Anna Reiling
- , Volker Endris
- , Thomas Hielscher
- , Anna Lena Volckmar
- , Olaf Neumann
- , Martina Kirchner
- , Jan Budczies
- , Lukas C. Heukamp
- , Jonas Leichsenring
- , Michael Allgäuer
- , Daniel Kazdal
- , Harald Löffler
- , Wilko Weichert
- , Peter Schirmacher
- , Albrecht Stenzinger
- , Alwin Krämer
- Universitätsklinikum Heidelberg
- Thoraxklinik at the University Hospital Heidelberg
- member of the German Centre for lung Research (DZL)
- German Cancer Research Center
- Institute for Haematopathology Hamburg
- Marien Hospital Stuttgart
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations